SAMN47003718
External Id
dbGaP
INSDC center name
2025-02-25T12:34:40.230Z
INSDC first public
2025-04-26T10:30:53.453Z
INSDC last update
SRS24353441
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS24353441
SRA accession
DNA
analyte type
NCI_AtezolizumabNeoantigen_UrothelialCancer
biospecimen repository
S18
biospecimen repository sample id
Blood
body site
phs003922
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
7464297
gap_sample_id
5602623
gap_subject_id
No
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Clinical Trial
study design
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
study name
S18
submitted sample id
GU007
submitted subject id
NCI_AtezolizumabNeoantigen_UrothelialCancer
submitter handle
Non-tumor DNA sample from Blood of a human male participant in the dbGaP study "Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial"
title